Navigation Links
CuraGen to Present CR011-vcMMAE Data at ASCO
Date:5/28/2009

- Update from Advanced Breast Cancer and Melanoma Studies

- Conference Call to be Hosted on Wednesday, June 3, 2009 at 11:00 am

BRANFORD, Conn., May 28 /PRNewswire-FirstCall/ -- CuraGen Corporation (Nasdaq: CRGN) today announced plans for three data presentations from its ongoing clinical trials of CR011-vcMMAE, an antibody-drug conjugate that targets GPNMB, in patients with advanced breast cancer and melanoma at the 2009 Annual Meeting of the American Society of Clinical Oncology (ASCO) in Orlando, Florida.

The titles, dates, and times of the presentations are as follows:

#9032 A phase I/II study of CR011-vcMMAE, an antibody-drug conjugate targeting glycoprotein NMB in patients with advanced melanoma. Sunday, May 31, 2009, poster presentation from 8:00 AM - 12:00 PM with a discussion session from 11:30 AM - 12:30 PM.

#9063 Pharmacokinetics of CR011-vcMMAE, an antibody-drug conjugate, in a phase I study of patients with advanced melanoma. Monday, June 1, 2009, poster presentation from 8:00 AM - 12:00 PM.

#1067 A phase I/II study of CR011-vcMMAE, an antibody-drug conjugate, in patients with locally advanced or metastatic breast cancer. Monday, June 1, 2009, poster presentation from 1:00 PM - 5:00 PM.

Abstracts are available and can be viewed on the ASCO Web site at www.asco.org.

Reprints of the presentations will be made available on CuraGen's website at http://www.curagen.com or can be requested by emailing info@cu
'/>"/>

SOURCE CuraGen Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. CuraGen Provides Update on Velafermin, Belinostat and CR011-vcMMAE Clinical Development Programs
2. CuraGen and TopoTarget Initiate Phase I/II Clinical Trial of Belinostat (PXD101) Combination Therapy for Acute Myeloid Leukemia
3. CuraGen Announces Top-Line Phase II Results on Velafermin
4. CuraGen Announces Presentation of Phase I Dose-Escalation Results on CR011- vcMMAE for Metastatic Melanoma
5. CuraGen and TopoTarget Announce Presentation of Belinostat Clinical Trial Results at AACR-NCI-EORTC International Conference
6. CuraGen and TopoTarget Announce Presentations on Belinostat at the Upcoming American Society of Hematology 49th Annual Meeting
7. CuraGen Advances CR011-vcMMAE into Phase II
8. CuraGen Announces Data From Ongoing Phase I/II Trial Showing Clinical Activity of CR011-vcMMAE in Metastatic Melanoma
9. CuraGen Announces Expansion of CR011-vcMMAE Phase II Trial in Melanoma
10. CuraGen Announces Initiation of Phase II Trial of CR011-vcMMAE in Patients with Advanced Breast Cancer
11. CuraGen Reports Second Quarter 2008 Financial Results and Clinical Progress of CR011-vcMMAE
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... , May 17, 2013  Atossa Genetics, Inc. (NASDAQ: ... Kyle Guse , Chief Financial Officer & ... MicroCap Conference on Thursday, May 30, 2013, in ... The Company,s presentation is scheduled to begin ... live webcast. To access the webcast, go to www.atossagenetics.com ...
(Date:5/17/2013)... NATICK, Mass. , May 17, 2013  Boston ... to participate at the annual EuroPCR Scientific Program May ... "We are pleased to present a particularly rich and ... Keith Dawkins , M.D., global chief ... several trials will be presented, including the NG PROMUS ...
(Date:5/16/2013)...  Nektar Therapeutics, (Nasdaq: NKTR ) President and ... is scheduled to present at the upcoming 2013 UBS Global ... the Sheraton New York Hotel on Tuesday, May 21, 2013 ... be accessible via a Webcast through a link posted in ... http://www.nektar.com . This Webcast will be available for replay ...
Breaking Medicine Technology:Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference 2Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference 3Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 2Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 3Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 4Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 5Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 6Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 7Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 8Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the 2013 UBS Global Healthcare Conference in New York City 2
... DailyMed(TM) Launches Innovative Solution to Medication Mismanagement ... ... medication,mismanagement continue to mount, emphasizing the urgent need for a,systematic change in ... At least 1.5 million Americans are sickened, injured or,killed each year by ...
... (N30), a,biopharmaceutical company focused on the discovery, development, ... today that it has successfully completed Phase 1,study ... develop N30-201 for,the treatment of reactive and obstructive ... are pleased to have begun and completed the ...
Cached Medicine Technology:More Than 1.5 Million Americans Sickened, Injured or Killed by Medication Errors Each Year; Seniors Most at Risk 2More Than 1.5 Million Americans Sickened, Injured or Killed by Medication Errors Each Year; Seniors Most at Risk 3More Than 1.5 Million Americans Sickened, Injured or Killed by Medication Errors Each Year; Seniors Most at Risk 4
(Date:5/18/2013)... (PRWEB) May 18, 2013 MOOSGO.COM published an ... , This book features a group of artists who share ... music, photographs, illustrations and paintings. Exclusively for iPad ... pieces including songs and videos that reflect the signature idiosyncrasy ... download at the Apple iBook Store and it includes ...
(Date:5/18/2013)... Assisted living and retirement communities ... and comfort of their residents. Systems Technologies is ... an effective and cost-efficient solution – VisionLink Wireless ... turnkey communications solution that helps nurses provide the ... and privacy. , The VisionLink nurse ...
(Date:5/18/2013)... Reporter , , FRIDAY, May 17 (HealthDay News) -- It comes ... new research shows that college women are more likely to ... are college men. Much of this difference is ... a weekly basis is much lower for women than it ... men. But, there,s good reason for that difference. Women don,t ...
(Date:5/18/2013)... York, New York (PRWEB) May 18, 2013 ... to mount in courts throughout the country, Bernstein Liebhard ... metal-on-metal hip replacement patients often suffer tissue damage before ... the study, which according to Science Daily will appear ... metal-on-metal hip replacement recipients underwent MRI screens of their ...
(Date:5/18/2013)... 6Webs.com is the leader in home ... comprehensive comparisons make 6Webs.com the useful resource consumers prefer ... recently finished conducting their assessments of the leading wireless ... 6Webs.com reports, "There has been an increase interest in ... use, expandability and mobility. Combine these features with the ...
Breaking Medicine News(10 mins):Health News:New Art Book for iPad: Tango Art 2Health News:VisionLink Nurse Call System's New Features Serve the Unique Needs of Retirement Communities 2Health News:VisionLink Nurse Call System's New Features Serve the Unique Needs of Retirement Communities 3Health News:College Women More Prone to Problem Drinking Than Men: Study 2Health News:College Women More Prone to Problem Drinking Than Men: Study 3Health News:Metal-on-Metal Hip Implants: Bernstein Liebhard LLP Comments on New Study Finding that Tissue Damage Precedes Pain in Metal-on-Metal Hip Replacement Patients 2Health News:Metal-on-Metal Hip Implants: Bernstein Liebhard LLP Comments on New Study Finding that Tissue Damage Precedes Pain in Metal-on-Metal Hip Replacement Patients 3Health News:Metal-on-Metal Hip Implants: Bernstein Liebhard LLP Comments on New Study Finding that Tissue Damage Precedes Pain in Metal-on-Metal Hip Replacement Patients 4Health News:Best Wireless Home Security System Companies Released by 6Webs.com 2
... flu in ducks on Indonesia's resort island of Bali, health ... of bird flu// . The birds had been smuggled to ... Putra, senior government veterinarian. ,More than 24 bird ... most populous nation. In response to the above situation, import ...
... Bolivar University in Caracas found that Lactobacillus casei (L ... flatulence capacity// and increased the nutritional value. Beans are ... the developing countries. ,Marisela Granito led the ... beans but not compromising on the nutritional value. The ...
... men are more aware of potential rivals for love when ... that men// become more jealous and wary of dominant males ... ,The Evolution and Human Behaviour study by the ... were vary wary of the dominant looking men who attract ...
... has been launched by Watson Pharmaceuticals, Inc. , ... agreement with Bristol-Myers Squibb Company. Shipments of pravastatin ... the 10, 20 and 40 mg strengths. ... Corona, CA. It is a leading specialty pharmaceutical ...
... they have found a new way to boost the immune ... at risk for developing various infections since their immune systems ... published in the online edition of the journal Blood on ... Division of Infectious Diseases show that the newborn immune system ...
... researchers suggests that injuries related to wearing glasses account ... of protective eyewear while engaging in activities that increase ... ,The researchers estimated that, in 2002 and 2003, ... treatment for injuries related to wearing glasses. More than ...
Cached Medicine News:Health News:Jealousy In Men Peaks When Partners Are Most Fertile 2Health News:Enhancing Infants Immune System 2Health News:Enhancing Infants Immune System 3Health News:Watch Out! Eye Glass Related Injuries On The Rise 2Health News:Watch Out! Eye Glass Related Injuries On The Rise 3
... material have been applied to a new Pe.R.I. ... ultra-low profile combine to provide a complete set ... ,This complete set of periarticular plates consists of: ... Composite Plate , Spider Plate ...
Standard Trephine...
X-Hair Trephines...
Corneal Marking Pen - Sterile. 10 pieces/box...
Medicine Products: